SOLASTA Bio, a Glasgow-based agri-biotech firm, has successfully raised $14 million (c. £10.7m) in Series A funding to advance its groundbreaking nature-inspired bioinsecticides.
The West of Scotland Space Cluster, the newest addition to the UK’s thriving ecosystem of regional space clusters, has launched ahead of Space-Comm Expo Scotland at SEC Glasgow 11-12 September, one of the year’s biggest UK space industry events.
HonuWorx, a Scottish underwater robotics company, has received a seven-figure investment to advance its plans to transform operations in the energy and security sectors.
Metacarpal – a startup behind what is thought to be the world’s first mechanical bionic hand – has secured £800,000 in seed funding to accelerate its prosthetics development and improve the lives of amputees.
Scottish Enterprise is investing £8 million in the construction of the University of Dundee’s Life Sciences Innovation Hub, a new £40m facility set to open next year.
Edinburgh-based biotech firm OGI Bio has beaten off competition from nine local tech startups to be crowned Scotland’s Tech Innovator 2024 in KPMG’s UK-wide competition.
Edinburgh-based biotech firm OGI Bio has secured follow-on funding of £650,000 in a deal led by TRICAPITAL Angels and supported by Scottish Enterprise, Merleview, Apollo, and Old College Capital.
Robertson Construction Central East has successfully delivered the £12 million 4D Cellular Medicine Building that will support cancer and health research for the University of Edinburgh.
This week, Glasgow-based Global PR & creative agency Smarts was recognised in three categories within PR Week’s esteemed Top 150 rankings; named the largest agency outside of London, 30th largest agency in the UK overall, and the 4th largest consumer agency.
Glasgow-headquartered clinical research facility, NeuroClin, has appointed Fiona Wood as its new CEO and confirmed an agreement has been reached to open a new site in North West England this Autumn.
The Sustainable Aquaculture Innovation Centre (SAIC) has secured new funding to continue its support of fish health research and development (R&D), delivered in collaboration between the private and public sectors.
Nebu-Flow, a University of Glasgow spinout developing next-generation inhaled drugs for respiratory disorders, has secured an additional £4.7 million investment.